4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-24-001484
Director sold 20,054 shares at an average $13.62 ($273,202)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Borgeson Blake · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-09 | Sale : show line 1 in the form 10b5-1 | −6,303 | $13.21 | $83,278 | 7,358,169 | D |
| 2024-01-09 | Sale : show line 2 in the form 10b5-1 | −13,751 | $13.81 | $189,925 | 7,344,418 | D |
| Open-market sales · 20,054 sh · avg $13.62 · $273,202 | ||||||
Loading xslF345X05/doc4.xml…